[HTML][HTML] Stability considerations for bacteriophages in liquid formulations designed for nebulization
Pulmonary bacterial infections present a significant health risk to those with chronic
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization
R Flint, DR Laucirica, HK Chan, BJ Chang… - …, 2023 - research-repository.uwa.edu.au
Pulmonary bacterial infections present a significant health risk to those with chronic
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization
R Flint, DR Laucirica, HK Chan, BJ Chang… - Cells, 2023 - pubmed.ncbi.nlm.nih.gov
Pulmonary bacterial infections present a significant health risk to those with chronic
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization.
R Flint, DR Laucirica, HK Chan, BJ Chang… - Cells (2073 …, 2023 - search.ebscohost.com
Pulmonary bacterial infections present a significant health risk to those with chronic
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization
R Flint, DR Laucirica, C Hak-Kim, BJ Chang, SM Stick… - Cells, 2023 - search.proquest.com
Pulmonary bacterial infections present a significant health risk to those with chronic
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
[HTML][HTML] Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization
R Flint, DR Laucirica, HK Chan, BJ Chang, SM Stick… - Cells, 2023 - ncbi.nlm.nih.gov
Pulmonary bacterial infections present a significant health risk to those with chronic
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization
R Flint, D Laucirica, H Chan, B Chang, S Stick, A Kicic - Cells, 2023 - europepmc.org
Pulmonary bacterial infections present a significant health risk to those with chronic
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization.
R Flint, DR Laucirica, HK Chan, BJ Chang, SM Stick… - Cells, 2023 - europepmc.org
Pulmonary bacterial infections present a significant health risk to those with chronic
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …
respiratory diseases (CRDs) including cystic fibrosis (CF) and chronic-obstructive pulmonary …